drugset / Trial / NCT06152653

The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)

NCT06152653

RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial is to determine if positive pressure during inspiration will improve penetration of aerosolized N-Acetylcysteine (NAC) into airway mucus plugs in the lungs of patients with asthma or Chronic Obstructive Pulmonary Disease (COPD). The main questions it aims to answer are: * Does delivery of aerosolized NAC with positive inspiratory pressure have a greater effect on mucus plug burden in the lungs than delivery of NAC without positive pressure. * Does delivery of aerosolized NAC with positive inspiratory pressure have a greater effect on lung function than delivery of NAC without positive pressure. Participants will be assigned (in a single blind design) to the NAC via jet nebulizer group or the NAC via AeroEclipse-VersaPAP nebulizer group. Participants will each complete 5 treatment visits over the course of 30 days. Each treatment visit will consist of two treatments of a 10% NAC (3 mL) and 2.5 mg albuterol (0.5mL) inhalation solution separated by 4 hours, via the nebulization method specific to their group.

Timeline

Start
2024-04-09
Primary completion
2027-04
Completion
2027-04

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 3 ml Inhaled
Subject N-acetylcysteine Small molecule 10 % Inhaled
Background Salbutamol Unknown 0.5 ml Inhaled
Background Salbutamol Unknown 2.5 mg Inhaled